Logo

OligoPeptide Manufacturer &
Generic Peptide API Supplier


Clinical Grade Tirzepatide Product Development

USA Bachem Pharma is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, and Lipid Nanoparticles (LNPs). With a team of scientific experts, cutting-edge technology, and a global network of fully integrated services, the Tirzepatide Firm delivers bespoke solutions spanning the entire drug lifecycle of liraglutide, tirzepatide injections, semaglutide injections and GLP-1 Peptides.

What We Do


USA Bachem Pharma ensures a dependable supply of generic peptides with a specialty in Tirzepatide, Semaglutide, and other GLP-1 peptides in bulk grams to kilograms. By leveraging the combined expertise of teams within our globally-integrated cGMP facility network, we offer tailored services for:

  • AP Peptides
  • Drug products
  • Lipid excipients
  • Peptide Oligos
  • We have supported many top brands establish a presence in the global market from early-phase clinical development to full-scale commercialization. 
What We Do Image

Meet Our GLP-1



Glucagon


Retatrutide


 


GLP-1 Solids

Your Trusted Partner in Pharmaceutical GLP-1 Peptides


Integrated CDMO Services for Semaglutide

We are an FDA-approved manufacturer of Tirzepatide and Semaglutide API; we specialize in cutting-edge peptides, including Retatrutide, Cagrillintide, and others. Our commitment to innovation ensures that we deliver high-quality API peptides for both research and clinical development in forms such as capsules, tablets, liquid injectables, and syrups. We are a global provider of peptides for research, clinical development, and commercial applications.

Semaglutide Image


Our Passion is Regenerative Medicines and Alternative Health Support Systems

 

USA Bachem Pharma is your CDMO partner for reliable, compliant, and innovative pharmaceutical manufacturing of NAD and peptides that helps humans be at their optimum health and balance. With decades of experience in peptides and injectable solutions, we bring together deep expertise and advanced infrastructure to support every stage of your drug’s development.

Brands Development

We have the top outsourced facility for major Tirzepatide, Semaglutide, Liraglutide, and Dulaglutide brands manufacturing and packaging, enabling pharmaceutical industries to keep up with the high demand of GLP-1 peptide products.

Global Footprint

Our network of facilities spans Switzerland, North America, Africa, and Europe, allowing us to offer flexible, efficient, and secure global support for every project scale and timeline.

           


Our Lipid & LNP Technology

USA Bachem Pharma is a global leader in pioneering the manufacture of lipid-based products for pharmaceutical development. We offer custom and standard synthetic lipids used in mRNA, siRNA, and DNA delivery.

No matter the scale or phase of development, we can support you in developing groundbreaking medicines with both custom and standard synthetic lipids. 

Peptide & API Development

USA Bachem Pharm is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.

The company, with over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide, offering a comprehensive range of services. 

Semaglutide Image
Semaglutide Image

Injectable Drug Products

We provide formulation, filling, and packaging of sterile injectables using cutting-edge technology in aseptic environments. 

Analytical & Regulatory Support

With a strong analytical infrastructure, we ensure every product meets strict regulatory guidelines through every phase of development. 

Semaglutide Image

Our Branded Products


Injectable Delivery

Injectable Tirzepatide

We provide formulation, filling, and packaging of sterile injectables using cutting-edge technology in aseptic environments.

Injectable Delivery

Powder Injectable Peptides

With a strong analytical infrastructure, USA Bachem ensures every product meets strict regulatory guidelines through every phase of development.

Our Product Collections

Latest News


Lilly Partners with US Firms

Breaking: Lilly Partners with US Firms to Make Mounjaro, Boost Supply

Eli Lilly announces strategic partnerships with US manufacturers to expand Mounjaro production capacity.

Read More →
Bachem Acquires Amwiner

Breaking: USA Bachem Corporation Acquires Amwiner in $2.3 Billion Pharma Deal

Major pharmaceutical acquisition strengthens peptide manufacturing capabilities in North America.

Read More →
Viking Amwiner Partnership

Viking & Amwiner Partner for Global GLP-1 Peptides Supply Chain

Strategic partnership aims to strengthen global supply chain for GLP-1 peptide therapeutics.

Read More →